Related content

Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis

By Roblin David   Yosipovitch Gil   Boyce Brent   Robinson John   Sandy James   Mainero Valentina   Wickramasinghe Ro   Anand Uma   Anand Praveen  

Acta Dermato-Venereologica, Vol. 95, Iss. 5, 2015-05 ,pp. : 542-548

Medical Journals Limited

Access to resources Recommend Favorite

Epidermal Insulin Resistance as a Therapeutic Target in Acanthosis Nigricans?

By Malisiewicz Bartosz   Boehncke Sandra   Lang Victoria   Boehncke Wolf-Henning   Buerger Claudia  

Acta Dermato-Venereologica, Vol. 94, Iss. 5, 2014-09 ,pp. : 607-608

Medical Journals Limited

Access to resources Recommend Favorite

Exacerbation of Psoriasis after Treatment with an EGFR Tyrosine Kinase Inhibitor

By Zorzou Markella-Pagona   Stratigos Alexandros   Efstathiou Eleni   Bamias Aristotle  

Acta Dermato-Venereologica, Vol. 84, Iss. 4, 2004-07 ,pp. : 308-309

Medical Journals Limited

Access to resources Recommend Favorite

The skin microbiome and immune system: Potential target for chemoprevention?

By  

Photodermatology, Photoimmunology & Photomedicine, Vol. 34, Iss. 1, 2018-01 ,pp. : 25-34

John Wiley & Sons Inc

Access to resources Recommend Favorite

Malassezia furfur induces the expression of -defensin-2 in human keratinocytes in a protein kinase C-dependent manner

By Donnarumma Giovanna  

Archives of Dermatological Research, Vol. 295, Iss. 11, 2004-04 ,pp. : 474-481

Springer Publishing Company

Access to resources Recommend Favorite